Return to Clinical Trials Search Results

EF-32: Pivotal, Randomized, open-label study of Tumor Treating Fields (OptuneÂ®, 200kHz) concomitant with radiation therapy and temozolomide for the treatment of newly diagnosed glioblastoma

Phase

Post-market

Recruitment Status

Past Studies

View on
ClinicalTrials.gov